Introduction
Natamycin is an antifungal agent used primarily to treat fungal infections, particularly those affecting the eyes (such as fungal keratitis) and the skin. It is classified as a polyene antifungal and is effective against a wide range of fungi, including yeast and mold species. Natamycin is typically available as an ophthalmic suspension or cream.
Uses
Natamycin is used for:
- Treatment of fungal eye infections, including fungal keratitis, blepharitis, and conjunctivitis
- Management of fungal infections of the skin
- Prevention of fungal growth in various food products (when used as a preservative)
| Brand Name | Natamycin |
|---|---|
| Type | |
| Weight | |
| Generic | Natamycin |
| Manufacturer | |
| Available in | English বাংলা |
Mechanism of Action
Natamycin works by binding to ergosterol, a vital component of fungal cell membranes. This binding disrupts the membrane’s integrity, leading to increased permeability, loss of essential cell contents, and eventually fungal cell death. Natamycin is fungicidal, meaning it actively kills fungi rather than just inhibiting their growth.
How Long Does It Take to Work?
The onset of action for natamycin is relatively quick, with patients typically experiencing relief from symptoms within 24 to 72 hours of initiating treatment. However, full resolution of the infection may take several days to weeks, depending on the severity and location of the fungal infection.
Absorption
Natamycin has very poor systemic absorption when applied topically, especially in ophthalmic use. It remains confined to the site of application (eye or skin) and is not well absorbed into the bloodstream, minimizing systemic effects.
Route of Elimination
Since natamycin is not systemically absorbed to a significant degree, its elimination is primarily through local metabolism at the site of application (eye or skin) and subsequent shedding of dead fungal cells. Any unabsorbed natamycin is excreted in the feces when ingested, though this is uncommon in its typical clinical use.
Dosage
For fungal keratitis: The preferred initial dosage is 1 drop instilled in the conjuntival sac (s) at 1-2 hours interval. The frequency of application can usually be reduced to 1 drop 6-8 times daily after the first 3-4 days. Therapy should generally be continued for 14 to 21 days or until there is resolution of active fungal keratitis.For fungal blepharitis & conjunctivitis: 1 drop 4-6 times daily may be sufficient.
Pediatric use: Safety and effectiveness in paediatric patients have not been established.
For fungal eye infections, the standard dosage of natamycin ophthalmic suspension is 1 drop instilled into the affected eye 4 to 6 times daily. The duration of treatment may vary from several days to weeks, depending on the severity of the infection and clinical response. For skin infections, natamycin cream is applied topically to the affected area 1 to 2 times daily.
Administration
Natamycin is administered either as an ophthalmic suspension or a topical cream. When used as an eye drop, shake the bottle well before each use and apply the prescribed number of drops into the affected eye(s). For topical administration, the cream is applied to clean, dry skin over the affected area. Follow your healthcare provider's instructions for both routes of administration.
Side Effects
Common side effects of natamycin include:
- Mild eye irritation or discomfort (for ophthalmic use)
- Redness or stinging of the eye
- Temporary blurred vision
- Allergic reactions such as rash, itching, or swelling
- Severe eye irritation
Toxicity
Natamycin is considered to have low toxicity, especially due to its poor systemic absorption. Overdose or accidental ingestion of topical or ophthalmic forms is unlikely to cause serious systemic effects. If eye irritation persists or worsens, medical attention may be needed.
Precautions
Precautions with natamycin include:
- Use cautiously in patients with a known hypersensitivity to natamycin or any other components of the formulation
- Do not wear contact lenses during treatment with natamycin ophthalmic suspension
- Discontinue use and consult a healthcare provider if severe eye irritation occurs
- Avoid use in the case of bacterial or viral eye infections without consultation
Interaction
There are no significant drug interactions reported with natamycin. Since it is not systemically absorbed, the risk of interactions with other medications is minimal.
Disease Interaction
There are no major disease interactions with natamycin, but it should not be used to treat bacterial or viral infections of the eye. It is only effective against fungal infections.
Drug Interaction
Natamycin does not have significant systemic drug interactions due to its minimal absorption. However, when used topically for eye infections, avoid using other ophthalmic medications simultaneously without consulting a healthcare provider, as they may interfere with the efficacy of natamycin.
Food Interactions
No known food interactions exist with natamycin. Since it is applied topically or ophthalmically, dietary intake does not influence its absorption or effectiveness.
Pregnancy Use
Natamycin is classified as a Category C drug in pregnancy, meaning there are no well-controlled studies in humans. However, due to its minimal systemic absorption, the risk to the fetus is considered low when used topically or ophthalmically. Consult your healthcare provider before using natamycin during pregnancy.
Lactation Use
It is not known whether natamycin is excreted in human breast milk. Given its poor systemic absorption, the risk to a nursing infant is likely low, but caution is advised. Consult with a healthcare provider before using natamycin while breastfeeding.
Acute Overdose
Due to its minimal systemic absorption, acute overdose of natamycin is unlikely to result in significant toxicity. In case of excessive use or accidental ingestion, symptomatic treatment may be provided. Seek medical attention if severe eye or skin irritation occurs.
Contraindication
Natamycin is contraindicated in patients with:
- Known hypersensitivity to natamycin or any component of the formulation
- Use in bacterial, viral, or protozoal infections of the eye or skin without appropriate diagnosis
Use Direction
For ophthalmic use, apply the recommended number of drops to the affected eye(s) as prescribed. Do not discontinue treatment prematurely, even if symptoms improve. For topical use, apply a thin layer of cream to the affected area. Follow the full course of treatment as directed by your healthcare provider.
Storage Conditions
Natamycin ophthalmic suspension and cream should be stored at room temperature (between 15°C and 30°C), protected from light and moisture. Keep the container tightly closed when not in use and out of reach of children.
Volume of Distribution
Natamycin has minimal systemic absorption; therefore, its volume of distribution is not significant or clinically relevant.
Half Life
Since natamycin is not systemically absorbed, it does not have a measurable half-life in the blood. Its duration of action is dependent on the frequency of application and the location of infection.
Clearance
Clearance of natamycin is primarily through local metabolism and sloughing off of the treated fungal cells at the site of application. Since it is not significantly absorbed systemically, renal or hepatic clearance is not relevant.
See in details version Natamycin also Natamycin in bangla
